GlaxoSmithKline plc. (GSK) is pharmaceutical company headquartered in Brantford in London in United Kingdom.
It was formed in 2000 when there was a merger between Glaxo Wellcome and SmithKline Beecham, and have ever since been a prominent brand in the industry. Recently in 2015 GSK was world’s sixth largest company, and was also listed on the London Stock Exchange along with the FTSE 100 Index.
GSK’s earned around £21.3 billion in 2013. GSK’s consumer products which were sold the most were Sensodyne and Aquafresh toothpaste, the malted-milk drink Horlicks, Nicoderm and Nicorette nicotine replacements, Abreva for cold sores, Night Nurse, a cold remedy and , Breathe Right nasal strips. The company was also instrumental in developing the first malaria vaccine.
GSK is on an acquisition spree in U.S. Pacific BioSciences are 1.6% higher after it has been speculated that it could be a target of $1.5bn bid. The possible bidders are GlaxoSmithKline and Roche. GSK is also seeking approval from US Food and Drug Administration, to release three-in-one inhaler to help patients suffering from chronic obstructive pulmonary disease by 2016. It plans to take approval from Europe at the same time.
GSK also got relief from court recently when the court did not find evidence in case of patient filing a law suit over GSK for failing to warn them about potential cardiovascular problems related to Avandia.